DAPERB 3,4-DiAminoPyridine and Electrophysiological Response in Brugada Syndrome

NCT00701077 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped recruitments issues

Conditions

Brugada Syndrome

Interventions

DRUG: 3,4-Di-amino-Pyridine
DRUG: placebo

Sponsor

Assistance Publique - Hôpitaux de Paris